作者
Carlo Briguori, Michael Donahue, Gabriella Visconti, Amelia Focaccio, Mauro Pennacchi, Luigi Lucisano, Rocco Stio, Massimo Mancone, Simone Calcagno, Vito Di Palma, Nicola Labalestra, Giuseppe Signoriello, Gennaro Sardella
发表日期
2017/3/1
期刊
Catheterization and Cardiovascular Interventions
卷号
89
期号
4
页码范围
E112-E123
简介
Objectives
To compare the safety and efficacy of the Axxess™ biolimus‐eluting stent with the second‐generation drug‐eluting stent (DES) in the treatment of bifurcation lesions.
Background
The Axxess™ is a dedicated bifurcation stent, designed to cover the lesion at the carina level.
Methods
Between April 2012 and August 2014, 165 patients with de novo bifurcation lesions were treated with the Axxess™ stent (Axxess group). A propensity‐score matched group of 165 patients treated with DES in the same period was selected (Control group). The primary objectives were (1) the procedural complication rate, including side branch (SB) occlusion and trouble in SB access after main vessel stenting; and (2) the device, the angiographic, and the procedural success rate.
Results
Procedural complications occurred in 1 patient (0.6%) in the Axxess group and in 20 patients (12%) in the Control group (OR = 0.03; 95 …
学术搜索中的文章
C Briguori, M Donahue, G Visconti, A Focaccio… - Catheterization and Cardiovascular Interventions, 2017